Of these, 11 (19%) patients had BRCA1/2-mutated tumors (7 BRCA1 and 4 BRCA2), 2 (4%) patients had tumors with BRIP1 mutations, and 1 (2%) patient had a tumor with a two-copy deletion of RAD51C (Fig. 2a, b). Here, BRCA1 is linked to neoplasm.